Development and clinical experience with the new evidence-based tocolytic atosiban. - Wikidata - awgldk - TriplyDB

Development and clinical experience with the new evidence-based tocolytic atosiban.

Development and clinical experience with the new evidence-based tocolytic atosiban.

http://www.wikidata.org/entity/Q34792360

about

Consequences of early experiences and exposure to oxytocin and vasopressin are sexually dimorphic.Oxytocin has dose-dependent developmental effects on pair-bonding and alloparental care in female prairie voles.Feto-placental communication system with the myometrium inpregnancy and parturition: the role of hormones, neurohormones, inflammatory mediators, and locally active factors.Therapy side-effects and predictive factors for preterm delivery in patients undergoing tocolysis with atosiban or ritodrine for threatened preterm labour.Uterine contractility and directed sperm transport assessed by hysterosalpingoscintigraphy (HSSG) and intrauterine pressure (IUP) measurement.

P2860

Q33647612-E9B8441C-24AC-435E-BE6F-69919A4597E3 Q35995814-0477D93C-15BE-4376-A8E9-194A843BF458 Q36475783-E248175A-E4E9-40A5-ABE5-F07EBD202834 Q40202592-798B312C-A960-4827-A4AC-98A567EB027B Q44789710-679163D4-8D80-4D33-A9EB-C7D0FB502FC0

P2860

Development and clinical experience with the new evidence-based tocolytic atosiban.

http://www.wikidata.org/entity/Q34792360

description

2002 nî lūn-bûn

@nan

2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Development and clinical experience with the new evidence-based tocolytic atosiban.

@ast

Development and clinical experience with the new evidence-based tocolytic atosiban.

@en

Development and clinical experience with the new evidence-based tocolytic atosiban.

@nl

type

label

Development and clinical experience with the new evidence-based tocolytic atosiban.

@ast

Development and clinical experience with the new evidence-based tocolytic atosiban.

@en

Development and clinical experience with the new evidence-based tocolytic atosiban.

@nl

prefLabel

Development and clinical experience with the new evidence-based tocolytic atosiban.

@ast

Development and clinical experience with the new evidence-based tocolytic atosiban.

@en

Development and clinical experience with the new evidence-based tocolytic atosiban.

@nl

P1433

Q34792360-6820FEE8-FBBF-4456-9A62-455C669461AA

P1476

Q34792360-A291E450-8898-4D1B-8B1D-CA11F8C14668

P2093

Q34792360-C6327902-20A1-4736-91C0-BAE8364FDE6C

P2860

Q34792360-09BD59F8-F578-4A16-B3E2-DFC9B0931325

Q34792360-09F59588-35A5-448C-B01F-FD702F36A805

Q34792360-213A8D85-252F-4382-952A-6E58BFDF84A2

Q34792360-4B0206E8-74FF-48EF-8366-15F7E0C53196

Q34792360-6E822C04-B8E4-463F-9A19-5C16CC5D28C5

Q34792360-7084D135-ED83-4036-AF34-8D0EC366A119

Q34792360-84081E15-F827-4BAE-B733-7F790A3D724A

Q34792360-8C125CB2-6ADD-4B52-97D4-F985C99BA50F

Q34792360-AA955457-071D-4D93-801B-F71BFEBE75BA

Q34792360-C6A90C6B-5E39-42F1-B3AB-1AFF3AF64DEF

P304

Q34792360-302ABEE0-DD3E-4ECB-8DC5-2EFAFB828A37

P31

Q34792360-96E7BAB8-DC5F-4578-BB53-77BBF354F404

P356

Q34792360-082FC057-A856-4149-A096-D6E3086327F5

P433

Q34792360-8F1FBF16-5FA1-4DBC-9AF1-8434D180DFDC

P478

Q34792360-C32E2470-7F6B-4DBD-A792-AFEB644523F7

P577

Q34792360-186927ED-06CF-4EEA-B2A2-40219970EE9C

P698

Q34792360-A9ADADDD-3B61-494C-8F35-A2B10C358B78

P356

J.1600-0412.2002.810709.X

P1433

Acta Obstetricia et Gynecologica Scandinavica

P1476

Development and clinical experience with the new evidence-based tocolytic atosiban.

@en

P2093

Peter Husslein

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.

The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin.

Synthesis of oxytocin in amnion, chorion, and decidua may influence the timing of human parturition.

Treatments of preterm premature rupture of the membranes: a meta-analysis.

Oxytocin receptors and human parturition: a dual role for oxytocin in the initiation of labor.

Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study.

Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.

Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors.

The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.

Treatment of preterm labor with the oxytocin antagonist atosiban.

P304

633-641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1034/J.1600-0412.2002.810709.X

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12190838

http://www.w3.org/2001/XMLSchema#string